NEONC TECHNOLOGIES HOLDINGS, INC.

Listed Company

NTHICIK 0001979414NasdaqEmerging GrowthPharmaceutical PreparationsDelawareFY ends Dec 31

Period

FY 2025

Revenue

$40.0K

Net Income

$-62.15M

Total Assets

$2.82M

Equity

$-17.51M

Shares Out

23.81M

Op. Cash Flow

$-20.36M

Business

NEONC TECHNOLOGIES HOLDINGS, INC. is a publicly listed company in Pharmaceutical Preparations, incorporated in Delaware. Common stock trades on Nasdaq under the ticker NTHI.

Auto-generated from company profile

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31
Revenue	39,990	83,000
Research and development	4	3
Legal and professional	2	2
General and administrative	5	2
Share based compensation	36	—
Advisory fees principally related parties	12	500,000
Total Operating Expenses	58	7
Loss From Operations	−58	−7
Interest and other income	327,582	16,133
Grant income	71,247	—
Amortization of debt issuance costs	−1	−145,097
Interest expense	−3	−3
Loss on extinguishment of Bridge loan related party	—	−2
Loss on change in fair value of derivative liability related to sales of common stock through equity line of credit	−689,543	—
Net Loss	−62	−12
Basic net loss per common share	−3.2	−0.69
Diluted net loss per common share	−3.2	−0.69
Weighted average shares used in computing basic net loss per common share	19	17
Weighted average shares used in computing diluted net loss per common share	19	17

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31
Cash and cash equivalents	58,729	64,893	—
Deferred offering costs current	75,082	1	—
Debt issuance costs current	671,804	671,804	—
Prepaid expenses and other current assets	583,096	386,559	—
Total Current Assets	1	2	—
Debt issuance costs net of current portion	526,701	1	—
Right of use asset operating lease	361,045	23,526	—
Other assets	47,177	—	—
Intangible asset	500,000	—	—
Total Assets	3	3	—
Accounts payable and accrued expenses	6	3	—
Accounts payable related parties	996,087	628,277	—
Accrued advisory fee related party	2	—	—
Litigation settlement payable	5	5	—
Convertible promissory notes, net of discount	6	—	—
Accrued compensation	255,099	734,874	—
Lease liability, current	71,131	24,722	—
Total Current Liabilities	20	9	—
Lease liability, net of current portion	290,682	—	—
Total Liabilities	20	9	—
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares were issued and outstanding as of December 31, 2025 and December 31, 2024	—	—	—
Common stock, $0.0001 par value, 100,000,000 shares authorized; 21,990,688 and 18,090,526 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively	2,198	1,809	—
Treasury stock 302,766 shares of common stock	−3	—	—
Additional paid in capital	98	45	—
Accumulated deficit	−113	−51	—
Total Stockholders Deficit	−18	−6	−14
Total Liabilities and Stockholders Deficit	3	3	—

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31
Increase in bridge loan expenses paid by bridge loan provider on behalf of the Company	—	476,393
Accretion of original issue discount on related party loan	300,000	3
Accretion of original issue discount on convertible promissory note	2	—
Write off deferred issuance costs	—	703,796
Loss on extinguishment of bridge loan	—	2
Loss on change in fair value of derivative liability	689,543	—
Amortization of debt issuance costs	1	145,097
Amortization of right of use asset	36,461	245,945
Prepaid expenses	−196,535	−123,627
Other assets	−47,177	—
Accrued compensation	−479,775	56,131
Lease liability	−12,167	−244,748
Accrued advisory fee related party	2	—
Accounts payable and accrued expenses	1	2
Net cash used in operating activities	−20	−4
Purchases of intangible asset	−500,000	—
Net cash used in investing activities	−500,000	—
Proceeds from the sale of common stock, net of costs	11	5
Proceeds from the sale of common stock private placement	1	—
Proceeds from related party loan	300,000	892,028
Repayment of related party loan	−600,000	−791,077
Deferred offering costs	—	−469,793
Proceeds from sale of common stock pursuant to equity purchase agreement	5	—
Proceeds from convertible notes payable	4	—
Net cash provided by financing activities	21	4
Net (decrease) increase in cash and cash equivalents	−6,164	33,031
Original issue discount on bridge loan related party	—	1
Right of use asset, at lease commencement	—	536,605
Share issued in connection with advisory services	557,060	—
Cashless exercise of warrants	2	—
Reclassified deferred offering costs to APIC at the completion of the offering	1	—
Increase in bridge loan payable prepaid and deferred offering costs paid directly by bridge loan provider on behalf of the Company	—	31,346
Conversion of bridge loan to common stock	—	12
Conversion of accrued compensation	—	412,500
Conversion of account payable to common stock	—	2
Tax effect related to net share settlement of equity awards	3	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro